Polyamine contents in current foods: a basis for polyamine reduced diet and a study of its long term observance and tolerance in prostate carcinoma patients
- 20 June 2007
- journal article
- Published by Springer Nature in Amino Acids
- Vol. 33 (2), 203-212
- https://doi.org/10.1007/s00726-007-0524-1
Abstract
Polyamine contents were assessed by mass spectrometry in 233 current foods and beverages. In order to reduce gut polyamine uptake, a polyamine reduced diet (PRD) and partial intermittent intestinal tract decontamination (PIITD) with neomycin or nifuroxazide was proposed as nutritional therapy to 33 prostate carcinoma patients, 30 of whom with hormone refractory prostate cancer (HRPC). Mean PRD observance was 22 ± 19 (median: 16; range: 3–72) months. 10, 8 and 3 patients were respectively on PRD for more than 30, 36 and 64 months. No diet toxicity was observed. 8 patients had moderate intestinal intolerance due to PIITD which was interrupted. No significant differences in body weight, blood counts or serum protein levels were observed during the follow-up of patients under PRD. Performance status and pain scores were relatively stable during the trial with improved pain scores at 6 months. A PRD associated with intermittent PIITD is a safe and well observed nutritional regimen and long term observance is possible.Keywords
This publication has 8 references indexed in Scilit:
- Atmospheric pressure chemical ionization-mass spectrometry method to improve the determination of dansylated polyaminesAnalytical Biochemistry, 2003
- Polyamine-reduced diet in metastatic hormone-refractory prostate cancer (HRPC) patientsBiochemical Society Transactions, 2003
- Chemotherapy for the Treatment of Hormone-Refractory Prostate CancerEuropean Urology Supplements, 2002
- Polyamine deprivation prevents the development of tumour-induced immune suppressionBritish Journal of Cancer, 1997
- The importance of dietary polyamines in cell regeneration and growthBritish Journal of Nutrition, 1995
- Polyamines and Prostatic Carcinoma: Clinical and Therapeutic ImplicationsEuropean Urology, 1993
- Erythrocyte Polyamine Levels in Human Prostatic CarcinomaJournal of Urology, 1990